Skip to content

News / Analytics / Reviews

Stock Market Analysis
Corporate News
Financial News

Earnings Snapshot: Abbott Laboratories beats consensus in Q3, tightens FY2024 outlook

Posted on October 16, 2024 by wpadmin

Posted in Corporate NewsTagged ABT

Post navigation

Previous: Intel’s products could face heat in China as cyber association calls for review: report

Next: Bank of America Q3: Why I Sold Shares After Earnings

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Δ

Search

Recent Posts

Salesforce, Snowflake, Oracle among Mizuho’s top enterprise software stocks for 2026
Global 2026 smartphone shipments forecast to decline due to memory shortage: Counterpoint
IonQ, D-Wave Quantum, Rigetti Computing in focus as Jefferies starts coverage
Nvidia, Broadcom among BofA’s top chip stocks for 2026
Tesla is forecast by Morgan Stanley to have one million robotaxis on the road by 2035

Recent Comments

Tom Ford on Affirm: A Genuine Innovation In Finance
Tim Donohue on Tilray Brands Q3 Earnings: Another Disappointing Quarter
PAUL URSUL on Lucid Troubles Keep Building
Warpaint on AT&T: A Classic Value Trap
Tyrion Lannister on Microsoft: AI, A Product Development Boon

Archives

Categories

Corporate News
Financial News
Stock Market Analysis

Powered By WordPress | Newsmagify